Aligned Health Ventures

Aligned Health Ventures is a seed-stage venture fund investing in health AI platforms. It targets chronic disease, behavioral health, metabolic syndrome, and maternal health, aiming to expand access, improve outcomes, and reduce burdens. The firm employs rigorous due diligence, scrutinizing algorithmic transparency, bias, regulatory viability, and data governance to ensure portfolio companies demonstrate clinical and economic impact.

Founded in 2022, Aligned Health Ventures was established by Israel Rollins, an entrepreneur experienced in life sciences and health information technology. The firm's core insight is that seed-stage investment critically shapes health AI companies' fundamental clinical assumptions and data architectures. This early engagement ensures ventures are intrinsically built to validate claims and align with value-based care models.

Portfolio companies must articulate measurable impact on patient outcomes, total cost of care, or service access, positioning them for value-based contracting and reimbursement. Aligned Health Ventures seeks to transform healthcare by supporting mission-driven platforms that achieve health impact and financial returns, attracting capital from mission-aligned investors and foundations.